Investor Relations

Corporate Profile
Over 45 million people in the U.S. have a substance use, addictive, or eating disorder. The National Institute on Drug Abuse (NIDA), a division of the National Institutes of Health (NIH), describes these disorders as chronic relapsing brain diseases, which burden society at both the individual and community levels. Opiant is a specialty pharmaceutical company developing treatments for substance use, addictive, and eating disorders.... More »
OPNT (Common Stock)
ExchangeOTC BB (US Dollar)
Financial Status IndicatorC
Price$8.27
Change (%) Stock is Up 0.57 (7.40%)
Volume1,825
Data as of 02/17/17 3:42 p.m. ET
Data provided by NASDAQ
Minimum 15 minuts delay
Refresh quote
Upcoming EventsMore Events »
There are currently no events scheduled.
What's NewMore Reports »
Download Documentation 2014 Annual Report
Receive E-mail Alerts
Sign up to receive e-mail alerts whenever Opiant Pharmaceuticals Inc posts new information to the site. Just enter your e-mail address and click Submit.
 
Print Page E-mail Page RSS Feeds E-mail Alerts IR Contacts Financial Tear Sheet